Last updated: August 3, 2025
Introduction
Patent KR20170048484, filed in South Korea, pertains to pharmaceutical innovations that potentially influence research and development strategies, licensing, and licensing negotiations within the region. As a key piece of intellectual property in the South Korean pharmaceutical sector, understanding its scope, claims, and place within the patent landscape is essential for stakeholders. This detailed analysis covers the patent’s scope, specific claims, the competitive landscape, and implications for industry players.
Overview of Patent KR20170048484
Patent KR20170048484 was granted by the Korean Intellectual Property Office (KIPO) in 2017, signaling its priority in the robust Korean pharmaceutical patent environment. The application likely addresses a novel aspect of drug formulation, manufacturing process, or a therapeutic compound, common in this patent class.
The patent's primary aim is to secure exclusive rights over a specific chemical entity, formulation, or method that offers a therapeutic advantage, aligning with South Korea’s strategic focus on innovative drug development. It covers the composition or process that is deemed novel, inventive, and industrially applicable under the criteria established by KIPO.
Scope of the Patent
1. Technical Domain
The patent resides in the domain of pharmaceutical compounds and associated formulations, possibly involving active pharmaceutical ingredients (API), delivery systems, or manufacturing techniques. The scope indicates protection for an innovative compound, a method to synthesize or formulate it, or a new therapeutic use.
2. Claims Structure and Breadth
The claims define the legal scope of the patent. Broad claims aim to cover a wide range of formulations or methods, while narrow claims focus on specific embodiments.
- Independent Claims: Likely specify the compound or formulation with particular structural features, dosage forms, or method of preparation.
- Dependent Claims: Further specify particular embodiments, such as dosage adjustments, delivery mechanisms, or combination therapies.
The scope can be summarized as protecting:
- A novel chemical entity or derivatives.
- A specific pharmaceutical composition involving the compound.
- A unique method of manufacturing or administering the drug.
3. Patent Term and Ammendments
The patent's expiration is usually in 2037, considering the 20-year term from priority date, subject to maintenance fees and any patent term adjustments.
Claims Analysis
Although the precise claim language isn't provided here, typical claims for such patents generally include:
- Chemical structure claims: Covering the molecular structure of the active compound, with specific substituents or stereochemistry.
- Method of synthesis: Protecting a novel process for preparing the compound.
- Formulation claims: Covering specific formulations, such as sustained-release or targeted delivery systems.
- Use claims: Protecting new therapeutic applications or indications.
Key aspects of the claims likely include:
- Structural features conferring advantageous pharmacokinetics or pharmacodynamics.
- Specific dosage ranges optimized for therapeutic efficacy.
- Composition claims for combination therapies.
The breadth and specificity of these claims influence the patent's enforceability and scope for licensing or litigation.
Patent Landscape in South Korea
1. Competitive Patent Environment
South Korea hosts a vibrant patent ecosystem, especially in pharmaceuticals, driven by innovation and high R&D investment. Major players include domestic companies such as Hanmi, LG Chem, and Samsung Bioepis, as well as international pharma firms.
This patent intersects with a crowded landscape, where overlapping patents may exist for compounds with similar structures, therapeutic targets, or delivery mechanisms.
2. Patent Families and Similar Patents
- The patent forms part of a broader family including applications in the U.S., Europe, and China.
- Similar patents may cover related chemical classes or therapeutic methods, requiring vigilant freedom-to-operate analyses.
- Overlapping patents from competitors could affect exclusive rights or licensing opportunities.
3. Patent Litigation and Challenges
South Korean patent law provides mechanisms for patent oppositions and litigations, which are common in this sector. Notably, software, formulations, and method claims are often challenged for novelty or inventive step.
The strategic importance of this patent in litigation or licensing depends on its claim strength and uniqueness compared to prior art.
Strategic Implications
1. Licensing and Commercialization
The patent’s scope, especially if broad, offers significant licensing potential within South Korea and internationally. Patent holders might target partnerships with local firms for manufacturing or distribution.
2. R&D and Competitive Edge
The patent provides a platform for further innovation, encouraging the development of next-generation formulations or combination therapies, leveraging the protected compound.
3. Regulatory and Market Access
Patent protection facilitates market exclusivity, aligning with South Korea’s regulatory framework that grants data exclusivity periods. This incentivizes investment and commercialization.
Conclusion
Patent KR20170048484 embodies a strategic innovation within South Korea’s pharmaceutical IP landscape, likely safeguarding a novel chemical compound, formulation, or process. Its scope is designed to balance broad protection with enforceability, giving its owner a competitive advantage in licensing and R&D.
The patent landscape’s dynamic nature requires continuous monitoring, especially considering potential patent overlaps and challenges. For stakeholders, understanding the precise claims and their scope informs licensing, research, and market strategies, ensuring optimized positioning in a competitive environment.
Key Takeaways
- The patent’s scope appears centered on protecting a specific chemical entity or formulation, with claims structured to cover synthesis, composition, and therapeutic use.
- Its influence extends across the patent landscape in South Korea, intersecting with other patents and technological innovations.
- Broad and well-crafted claims enhance enforceability and licensing prospects but must withstand scrutiny under patentability criteria.
- Strategic advantages include market exclusivity, licensing opportunities, and R&D incentives.
- Ongoing patent landscape analysis and monitoring of potential challenges are critical for maintaining the patent’s value.
FAQs
Q1: How does patent KR20170048484 compare to similar international patents?
Answer: It shares common structural features with international counterparts, likely protected under PCT filings or family patents. The scope depends on claim language, which is tailored for South Korea’s patent environment, possibly offering narrower or broader protection than counterparts outside Korea.
Q2: Can the claims of this patent be challenged in Korea?
Answer: Yes. Oppositions or invalidations can be initiated based on prior art, lack of novelty, or inventive step, especially if overlapping patents exist.
Q3: What is the potential lifetime of the patent?
Answer: Typically, 20 years from the filing date, usually expiring around 2037, assuming maintenance fees are paid.
Q4: How does this patent influence drug development in Korea?
Answer: It can serve as an R&D milestone and facilitate local manufacturing, licensing negotiations, or partnership formation, bolstering Korea’s domestic innovation ecosystem.
Q5: Are there any notable litigations involving this patent?
Answer: As of now, specific litigation involving KR20170048484 is unreported. However, patent litigations in Korea are common and can significantly influence a patent’s strategic value.
References
- Korean Intellectual Property Office (KIPO). Patent Search Database.
- Patent application document for KR20170048484.
- South Korean patent law and practice guidelines.
- Industry reports on South Korean pharmaceutical patent landscape.
